COMPARISON OF NEUTRALIZING ANTIBODY TITER AGAINST REBIF AND RECIGEN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS AND RELATION TO PATIENT’S DISABILITY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ASHTARI FERESHTEH; SHOKROLLAHI BAROUGH MAHDIEH; Asghari Nabiollah; KOKHAEI PARVIZ; Kokhaei Naser; Akhavi Mehdi Sadat

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Seminar Paper

Paper Information

Seminar: INTERNATIONAL MS CONGRESS OF IRAN
Year:2015 | Issue:12

Download Full-Text

View:

109

Download:

Information Seminar Paper

Title

COMPARISON OF NEUTRALIZING ANTIBODY TITER AGAINST REBIF AND RECIGEN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS AND RELATION TO PATIENT’S DISABILITY

Author(s)

Keywords

RRMS

RECIGEN

REBIF

NEUTRALIZING AB

Abstract

INTRODUCTION: MULTIPLE SCLEROSIS IS MOST COMMONLY NEURODEGENERATIVE AUTOIMMUNE DISEASE. ONE OF THE MAIN TREATMENT METHODS IN RELAPSED REMITTING MULTIPLE SCLEROSIS (RRMS) IS THE SUBCUTANEOUSLY ADMINISTRATION OF HUMAN RECOMBINANT INTERFERON BETA (IFN-B. THE IMMUNE SYSTEM OF PATIENTS RECEIVING THE DRUG MAY PRODUCE NEUTRALIZING ANTIBODIES AGAINST THIS DRUG AND IMPAIR THE DRUG FUNCTION. RECIGEN AND REBIF ARE TWO BRANDS OF RECOMBINANT IFN-B-1A. IN THIS STUDY THE TITER OF NEUTRALIZING ANTIBODIES IN TWO GROUPS OF PATIENTS RECEIVING RECIGEN AND REBIF WERE COMPARED...

Cites

No record.

References

No record.

Cite

APA: Copy

ASHTARI, FERESHTEH, SHOKROLLAHI BAROUGH, MAHDIEH, Asghari, Nabiollah, KOKHAEI, PARVIZ, Kokhaei, Naser, & Akhavi, Mehdi Sadat. (2015). COMPARISON OF NEUTRALIZING ANTIBODY TITER AGAINST REBIF AND RECIGEN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS AND RELATION TO PATIENT’S DISABILITY. INTERNATIONAL MS CONGRESS OF IRAN. SID. https://sid.ir/paper/921209/en

Vancouver: Copy

ASHTARI FERESHTEH, SHOKROLLAHI BAROUGH MAHDIEH, Asghari Nabiollah, KOKHAEI PARVIZ, Kokhaei Naser, Akhavi Mehdi Sadat. COMPARISON OF NEUTRALIZING ANTIBODY TITER AGAINST REBIF AND RECIGEN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS AND RELATION TO PATIENT’S DISABILITY. 2015. Available from: https://sid.ir/paper/921209/en

IEEE: Copy

FERESHTEH ASHTARI, MAHDIEH SHOKROLLAHI BAROUGH, Nabiollah Asghari, PARVIZ KOKHAEI, Naser Kokhaei, and Mehdi Sadat Akhavi, “COMPARISON OF NEUTRALIZING ANTIBODY TITER AGAINST REBIF AND RECIGEN IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENTS AND RELATION TO PATIENT’S DISABILITY,” presented at the INTERNATIONAL MS CONGRESS OF IRAN. 2015, [Online]. Available: https://sid.ir/paper/921209/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops